Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Mouse Monoclonal [clone 321621] (IgG1) to Human F7 / Factor VII
ICC, Western blot, Immunoprecipitation
Sheep Polyclonal (IgG) to Human F7 / Factor VII
Human F7 / Factor VII
Human (tested or 100% immunogen sequence identity)
IHC - Paraffin
Specificity and Use
F7 / Factor VII antibody was raised against human Factor VII (F. VII) purified from plasma.
Specific for Factor VII as demonstrated by immunoelectrophoresis and ELISA. No reactivity was observed with normal plasma by immunoelectrophoresis. Identity was established with purified human Factor VII by direct ELISA.
Suitable for use in Immunoelectrophoresis and ELISA.
10 mM HEPES, pH 7.4, 0.15 M sodium chloride, 50% glycerol.
Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles.
F7 Antibody, Coagulation factor VII Antibody, Eptacog alfa Antibody, F7 Deficiency Antibody, Factor 7 Antibody, Factor VIIa Antibody, FVII coagulation protein Antibody, Factor VII Antibody, FVII Antibody, SPCA Antibody, Factor VII Deficiency Antibody, Proconvertin Antibody
F7 / Factor VII is coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis. This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis. Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond.